1207993-84-7

Upstream product

• 5451-40-1 2,6 dichloropurine 
• 817160-16-0 1-(2-nitrobenzenesulfonyl)-3-methoxy-1,2,3,5-tetrahydro-4,1-benzoxazepine 

Downstream Products

• 1265578-56-0 (RS)-9-[1-(o-aminobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-2,6-dichloro-9H-purine 
• 1265578-58-2 (RS)-2,6-dichloro-9-[1-(o-hydroxylaminobenzene-sulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine 
• 1207993-85-8 (RS)-2-chloro-6-iodo-9-[1-(o-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine 
• 1265578-60-6 (RS)-2,6-dithiophenyl-9-[1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine 
• 1265578-62-8 (RS)-2-chloro-6-phenylthio-9-[1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine 

Relevant academic research and scientific papers

New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1- benzoxazepin-3-yl]-9H-purine

Completing an SAR study, a series of (RS)-6-substituted-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-7H or 9H-purines has been prepared under microwave-assisted conditions. Their antiproliferative activities on MCF-7 and MDA-MB-231 cancerous cell l